Technology & Digital Business Grants

The objective of the Ideas Grant scheme is to support innovative research projects addressing specific question(s). The expected outcomes are: • innovative and creative research • funding of researchers at all career stages • funding any area of health and medical research from discovery to implementation. It is expected that the CIA will have the capability to lead the team in achieving the project aims. Only applications that address the intended objective and outcomes will be competitive for funding. The Ideas Grant scheme is not intended to support research where a clinical trial or cohort study is the primary objective, and applications meeting that description should be submitted to the Clinical Trial and Cohort Studies Grant scheme. Where applications have elements consistent with both the Clinical Trials and Cohort Studies Grant scheme and the Ideas Grant scheme, applicants should decide where the project is predominantly suited, based on the objectives and intended outcomes of

The ESVCLP program supports fund managers and investors in stimulating early stage venture capital investments in Australia. Fund managers can raise venture capital funds between $10 million and $200 million to invest in innovative early stage businesses, while both fund managers and investors receive tax benefits including exemptions on income and gains from eligible investments.

A venture capital investment program that provides capital and professional expertise to innovative Australian early-stage companies and high-growth startups. The program offers increased fund sizes up to $200 million, a 10% tax offset on capital deployed into start-up companies, and a tax-exempt environment for investment returns.

A program that provides capital for early-stage venture capital limited partnerships to invest in innovative Australian businesses. The program attracts venture capital investors to high-potential sectors including agricultural technology, enabling funding for companies like SwarmFarm Robotics to develop and scale cutting-edge solutions.

A legislated tax offset program that supports companies to invest in eligible research and development by offsetting some of the associated costs. The program provides refundable or non-refundable tax offsets based on company turnover and R&D expenditure proportions, with offsets up to $150 million.

The Additive Manufacturing CRC establishes a world-class ecosystem for 3D printing technology spanning the entire value chain. It brings together Australia's AM research community and ambitious companies to accelerate innovation, explore new sustainable materials, and certify production, supporting widespread industrial adoption of AM technologies.

Funding for EPE Oceania Pty Ltd to design, build, test and operate Australia's first lunar rover on the Moon's south pole. This is the first Australian-led space mission to another celestial body, with $42 million in funding from the Australian Space Agency's Moon to Mars Program.

Partnership Projects will support collaborations, within the Australian context, that translate research evidence into health policy and health practice, to improve health services and processes. The objectives of the Partnership Project scheme are to: • Meet the need for more effective integration of research evidence into health policy and service delivery • Create partnerships among policy makers, managers, service providers and researchers • Provide support to answer often complex and difficult questions that policy makers, managers and service providers face when making decisions and implementing policies that affect Australians’ health and health care • Be highly responsive to the priorities of government, the community and health professionals • Enable applicants to apply for funding at any time during the year to allow researchers and Partner Organisations to develop timely collaborations. Eligibility: Appications will only be accepted from NHMRC approved Administering Institut

Grants to support medical research and medical innovation projects through the establishment of BioMedTech Incubators. The program funds eligible organisations to identify, select and support Australian SMEs undertaking early-stage medical research and innovation projects with commercial potential in areas such as biomarkers, diagnostics, therapeutics, assistive devices and digital technologies.

This grant program supports researchers pursuing innovative projects to develop new products and interventions in health and medical research, with the goal of creating treatments for serious and incurable health conditions. Funding supports programs of research comprising linked projects with a 10-year time horizon, from proof-of-concept through to full clinical implementation.

A new $20 million funding program to support companies developing high-tech innovations in NSW. The program supports research commercialisation and helps innovative small businesses bring their technologies to market.

The Energy Innovation Fund provides up to $17 million over five years in flexible, early-stage grants for energy innovation projects across three streams: Technology Demonstration, Policy Challenge, and Innovation Ecosystem. It aims to support new and emerging technologies while developing the ACT as an export-oriented hub for energy transition innovation to achieve net zero emissions by 2045.